Healthcare Equipment & Supplies
Key highlights
- India’s Healthcare Equipment & Supplies sector is supported by rising chronic disease incidence, ageing demographics, hospital expansion, government procurement and domestic-manufacturing policy support.
- Medical consumables and surgical dressings remain highly competitive categories, with pricing pressure from domestic producers, imported products, institutional tenders and potential trade-margin regulation.
- Galaxy Medicare delivered FY26 revenue of ₹40.00 Cr, up 2.0% from FY25, while EBITDA declined 6.5% to ₹4.30 Cr and EBITDA margin moderated to 10.8%.
- Galaxy Medicare has strong product concentration: POP Bandage and Elastic Adhesive Bandage represented 87% of FY26 revenue, while Bangladesh accounted for about 83% of export sales.
- Nureca reported consolidated H1 FY27 PAT of ₹7.12 Cr, up 60.4% year-on-year, but operating cash flow turned negative at ₹12.54 Cr due to inventory, receivable and other working-capital investment.
- Capacity additions, localisation, quality certifications, government procurement and exports are opportunities; input-cost volatility, tender-led pricing, regulatory compliance and high working-capital needs are the primary risks.
powered by IRIS
Unlock full access to this sectoral analysis with in-depth insights, comprehensive data, and exclusive reports.


